Sumitomo Dainippon Pharma Co Ltd - Total Cashflows From Investing Activities

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Total-Cashflows-From-Investing-Activities" stands at 29.94 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.

Sumitomo Dainippon Pharma Co Ltd's second quarter result of 31.95 Billion JPY for the item "Total Cashflows From Investing Activities" represents an increase of 840.57 percent compared to it's first quarter result.

Also, Sumitomo Dainippon Pharma Co Ltd's second quarter result of 31.95 Billion JPY for the item "Total Cashflows From Investing Activities" represents an increase of 784.11 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's second quarter result of 29.94 Billion JPY for the item "Total Cashflows From Investing Activities" represents an increase of 548.09 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -67.88 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -67.88 Billion Japanese Yens.
The 3 year change is 44.78 Billion Japanese Yens.
The 5 year change is 334.06 Billion Japanese Yens.
The 10 year change is -21.67 Billion Japanese Yens.

The Serie's long term average value is -3.59 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 33.53 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 12/31/2019, to it's latest available value, on 09/30/2025, is +345.48 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 09/30/2023, to it's latest available value, on 09/30/2025, is -76.84 Billion.